The Fracture Risk Assessment Tool Probability and Trabecular Bone Score Mediate the Relationship between Sphingosine 1-phosphate Levels and Fracture Risk

참고문헌 (32)

1. NIH Consensus Development Panel on Osteoporosis Prevention D, and Therapy, "Osteoporosis prevention, diagnosis, and therapy", JAMA, 285, pp.785~795 (2001)[DOI]
2. Camacho PM, "American association of clinical endocrinologists and American college of endocrinology clinical practice guidelines for the diagnosis and treatment of postmenopausal osteoporosis-2016-executive summary", Endocr Pract, 22, pp.1111~1118 (2016)[DOI]
3. National Osteoporosis Foundation, "Clinician’s guide to prevention and treatment of osteoporosis", National Osteoporosis Foundation, ~ (2014)
4. Sanders KM, "Half the burden of fragility fractures in the community occur in women without osteoporosis. When is fracture prevention cost-effective?", Bone, 38, pp.694~700 (2006)[DOI]
5. Siris ES, "Bone mineral density thresholds for pharmacological intervention to prevent fractures", Arch Intern Med, 164, pp.1108~1112 (2004)[DOI]
6. Kanis JA, "Interpretation and use of FRAX in clinical practice", Osteoporos Int, 22, pp.2395~2411 (2011)[DOI]
7. Harvey NC, "Trabecular bone score(TBS)as a new complementary approach for osteoporosis evaluation in clinical practice", Bone, 78, pp.216~224 (2015)[DOI]
8. McCloskey EV, "A meta-analysis of trabecular bone score in fracture risk prediction and its relationship to FRAX", J Bone Miner Res, 31, pp.940~948 (2016)[DOI]
9. Silva BC, "Trabecular bone score : a noninvasive analytical method based upon the DXA image", J Bone Miner Res, 29, pp.518~530 (2014)[DOI]
10. Nguyen TV, "Fracture risk assessment : from population to individual", J Clin Densitom, 20, pp.368~378 (2017)[DOI]
11. Leslie WD, "Spine bone texture assessed by trabecular bone score(TBS)predicts osteoporotic fractures in men : the Manitoba Bone Density Program", Bone, 67, pp.10~14 (2014)[DOI]
12. Leslie WD, "Lumbar spine texture enhances 10-year fracture probability assessment", Osteoporos Int, 25, pp.2271~2277 (2014)[DOI]
13. Grey A, "The phospholipids sphingosine-1-phosphate and lysophosphatidic acid prevent apoptosis in osteoblastic cells via a signaling pathway involving G(i)proteins and phosphatidylinositol-3 kinase", Endocrinology, 143, pp.4755~4763 (2002)[DOI]
14. Grey A, "Osteoblastic cells express phospholipid receptors and phosphatases and proliferate in response to sphingosine-1-phosphate", Calcif Tissue Int, 74, pp.542~550 (2004)[DOI]
15. Roelofsen T, "Sphingosine-1-phosphate acts as a developmental stage specific inhibitor of platelet-derived growth factor-induced chemotaxis of osteoblasts", J Cell Biochem, 105, pp.1128~1138 (2008)[DOI]
16. Ishii M, "Sphingosine-1-phosphate mobilizes osteoclast precursors and regulates bone homeostasis", Nature, 458, pp.524~528 (2009)[DOI]
17. Ishii M, "Chemorepulsion by blood S1P regulates osteoclast precursor mobilization and bone remodeling in vivo", J Exp Med, 207, pp.2793~2798 (2010)[DOI]
18. Ryu J, "Sphingosine 1-phosphate as a regulator of osteoclast differentiation and osteoclast-osteoblast coupling", EMBO J, 25, pp.5840~5851 (2006)[DOI]
19. Lee SH, "Higher circulating sphingosine 1-phosphate levels are associated with lower bone mineral density and higher bone resorption marker in humans", J Clin Endocrinol Metab, 97, pp.E1421~E1428 (2012)[DOI]
20. Mohammed-Salleh M. Ardawi, "High Plasma Sphingosine 1-phosphate Levels Predict Osteoporotic Fractures in Postmenopausal Women: The Center of Excellence for Osteoporosis Research Study", 대한골대사학회지, 25(2), pp.87~98 (2018), 대한골대사학회[DOI]
21. Bae SJ, "The circulating sphingosine-1-phosphate level predicts incident fracture in postmenopausal women: a 3.5-year follow-up observation study", Osteoporos Int, 27, pp.2533~2541 (2016)[DOI]
22. Kim BJ, "Plasma sphingosine 1-phosphate levels and the risk of vertebral fracture in postmenopausal women", J Clin Endocrinol Metab, 97, pp.3807~3814 (2012)[DOI]
23. Lee SH, "High circulating sphingosine 1-phosphate is a risk factor for osteoporotic fracture independent of fracture risk assessment tool", Calcif Tissue Int, 107, pp.362~370 (2020)[DOI]
24. Lee SH, "Associations of circulating levels of sphingosine 1-phosphate with the trabecular bone score and bone mineral density in postmenopausal women", J Clin Densitom, 24, pp.414~421 (2021)[DOI]
25. Genant HK, "Vertebral fracture assessment using a semiquantitative technique", J Bone Miner Res, 8, pp.1137~1148 (1993)[DOI]
26. Kiel D, "Assessing vertebral fractures. National osteoporosis foundation working group on vertebral fractures", J Bone Miner Res, 10, pp.518~523 (1995)[DOI]
27. Bahk J, "Impact of unintended pregnancy on maternal mental health : a causal analysis using follow up data of the Panel Study on Korean Children(PSKC)", BMC Pregnancy Childbirth, 15, pp.85~ (2015)[DOI]
28. Rosen H, "Sphingosine 1-phosphate and its receptors : an autocrine and paracrine network", Nat Rev Immunol, 5, pp.560~570 (2005)[DOI]
29. Maceyka M, "Sphingosine-1-phosphate signaling and its role in disease", Trends Cell Biol, 22, pp.50~60 (2012)[DOI]
30. Kunkel GT, "Targeting the sphingosine-1-phosphate axis in cancer, inflammation and beyond", Nat Rev Drug Discov, 12, pp.688~702 (2013)[DOI]
31. Soysal P, "Inflammation and frailty in the elderly : a systematic review and meta-analysis", Ageing Res Rev, 31, pp.1~8 (2016)[DOI]
32. Rivera J, "The alliance of sphingosine-1-phosphate and its receptors in immunity", Nat Rev Immunol, 8, pp.753~763 (2008)[DOI]